Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Knoop, Karol
FLUTE-3, NCT05634746: 24-Week Induction Study of APT-1011 in Adult Subjects with Eosinophilic Esophagitis (EoE) (FLUTE 3)	Completed	3	218	Canada, US	APT-1011, Placebo oral tablet, Esophagogastroduodenoscopy	Ellodi Pharmaceuticals, LP	Eosinophilic Esophagitis	08/24	08/24
Ben-Yair, Vered Katz
FLUTE-3, NCT05634746: 24-Week Induction Study of APT-1011 in Adult Subjects with Eosinophilic Esophagitis (EoE) (FLUTE 3)	Completed	3	218	Canada, US	APT-1011, Placebo oral tablet, Esophagogastroduodenoscopy	Ellodi Pharmaceuticals, LP	Eosinophilic Esophagitis	08/24	08/24